Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics Employees

As of December 31, 2023, Inhibikase Therapeutics had 9 total employees, including 8 full-time and 1 part-time employees. The number of employees increased by 2 or 28.57% compared to the previous year.

• Employees: 9
• Change (1Y): 2
• Growth (1Y): 28.57%
• Revenue / Employee: $21,776
• Profits / Employee: -$2,133,416
• Market Cap: 10.82M

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	9	2	28.57%
Dec 31, 2022	7	0	-
Dec 31, 2021	7	4	133.33%
Dec 31, 2020	3	-	-